|
FAM83D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.144400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.878100E-02 |
| Normal-vs-Stage2 |
2.986400E-01 |
| Normal-vs-Stage3 |
1.494380E-01 |
| Normal-vs-Stage4 |
5.319600E-02 |
| Stage1-vs-Stage2 |
9.240000E-01 |
| Stage1-vs-Stage3 |
8.707000E-01 |
| Stage1-vs-Stage4 |
4.217200E-01 |
| Stage2-vs-Stage3 |
8.691400E-01 |
| Stage2-vs-Stage4 |
7.164400E-01 |
| Stage3-vs-Stage4 |
4.491000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.989530E-02 |
| Normal-vs-AfricanAmerican |
5.166600E-01 |
| Normal-vs-Asian |
2.122000E-01 |
| Caucasian-vs-AfricanAmerican |
4.650400E-01 |
| Caucasian-vs-Asian |
6.936800E-01 |
| AfricanAmerican-vs-Asian |
6.892000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.916500E-02 |
| Normal-vs-Female |
8.354200E-02 |
| Male-vs-Female |
2.920000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.757860E-02 |
| Normal-vs-Age(41-60Yrs) |
7.516200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.725900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.016200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.755030E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.110400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.839160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.522000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.618200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.226100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.248400E-01 |
| Classical-VS-Follicular |
2.756400E-02 |
| Classical-VS-Other |
4.267800E-01 |
| Classical-VS-Normal |
1.225960E-02 |
| Tall-VS-Follicular |
1.431590E-01 |
| Tall-VS-Other |
4.313600E-01 |
| Tall-VS-Normal |
1.341230E-01 |
| Follicular-VS-Other |
9.303200E-01 |
| Follicular-VS-Normal |
7.976400E-01 |
| Other-VS-Normal |
9.747600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.579960E-01 |
| Normal-vs-N1 |
1.357780E-01 |
| N0-vs-N1 |
6.991200E-01 |
|
|
